Home » Authors » Brady Huggett

Articles by Brady Huggett

Aderis Postpones IPO; Market Seen As 'Discerning' This Time

Oct. 30, 2003

By Brady Huggett

Aderis Postpones IPO; Market Seen As 'Discerning' This Time

Oct. 30, 2003

By Brady Huggett

CytRx Farms Out Flocor To SynthRx, Focuses On RNAi

Oct. 24, 2003

By Brady Huggett

CytRx Farms Out Flocor To SynthRx, Focuses On RNAi

Oct. 24, 2003

By Brady Huggett

Durect Stock Falls 35 Percent On Likely Phase III Trial Delay

Oct. 20, 2003

By Brady Huggett

Durect Stock Falls 35 Percent On Likely Phase III Trial Delay

Oct. 20, 2003

By Brady Huggett

'On Track' Genentech Beats Street With Positive Earnings

Oct. 10, 2003

By Brady Huggett

'On Track' Genentech Beats Street With Positive Earnings

Oct. 10, 2003

By Brady Huggett

Biogen Licenses Psoriasis Product From Fumapharm

Oct. 2, 2003

By Brady Huggett

Biogen Licenses Psoriasis Product From Fumapharm

Oct. 2, 2003

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 22, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 21, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...
Medtronic receives CE mark for next generation Endoflip system
BioWorld MedTech
Medtronic plc obtained a CE mark for its next generation Endoflip 300 system which measures pressure and dimensions in the esophagus and pylorus, in adults. The...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.